Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Mourits

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Disability and Rehabilitation|November 18, 2024
Evaluation of participation in a former rehabilitation population: a comparison between USER-Participation Restriction and Satisfaction subscales and PROMIS Ability to Participate and PROMIS Satisfaction with participation 8-item short forms in a cross-sectional multicentre studyB M P Mourits, E W M Scholten, J A de Graaf, et al.
Disability and Rehabilitation|October 9, 2025
The experiences of rehabilitation healthcare professionals with the use of the self-regulation assessment (SeRA) in routine care: a qualitative pilot studyB M P Mourits, J M P Leenders, E W M Scholten, et al.
Clinical Rehabilitation|January 23, 2026
Test-retest reliability and responsiveness of the Self-Regulation Assessment in a rehabilitation population: A prospective multicentre validation studyB M P Mourits, E W M Scholten, J A de Graaf, et al.
The Journal of Clinical Endocrinology and Metabolism|October 6, 2012
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathyL Bartalena, G E Krassas, W Wiersinga, et al.
European Journal of Endocrinology|July 27, 2006
A questionnaire survey on the management of Graves' orbitopathy in Europe, P Perros, L Baldeschi, et al.
Journal of Endocrinological Investigation|February 9, 2017
Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?L Bartalena, G Veronesi, G E Krassas, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 5, 2026
Measurement properties of the USER-Participation Restriction subscale and PROMIS<sup>®</sup> Ability to Participate in Social roles and Activities in in- and outpatient rehabilitation populationsB M P Mourits, E W M Scholten, J A de Graaf, et al.
European Journal of Endocrinology|August 18, 2006
Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers, W M Wiersinga, P Perros, et al.
The British Journal of Ophthalmology|November 26, 2008
Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures, M P Mourits, H Bijl, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Disability and Rehabilitation|November 18, 2024
Evaluation of participation in a former rehabilitation population: a comparison between USER-Participation Restriction and Satisfaction subscales and PROMIS Ability to Participate and PROMIS Satisfaction with participation 8-item short forms in a cross-sectional multicentre studyB M P Mourits, E W M Scholten, J A de Graaf, et al.
Disability and Rehabilitation|October 9, 2025
The experiences of rehabilitation healthcare professionals with the use of the self-regulation assessment (SeRA) in routine care: a qualitative pilot studyB M P Mourits, J M P Leenders, E W M Scholten, et al.
Clinical Rehabilitation|January 23, 2026
Test-retest reliability and responsiveness of the Self-Regulation Assessment in a rehabilitation population: A prospective multicentre validation studyB M P Mourits, E W M Scholten, J A de Graaf, et al.
The Journal of Clinical Endocrinology and Metabolism|October 6, 2012
Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathyL Bartalena, G E Krassas, W Wiersinga, et al.
European Journal of Endocrinology|July 27, 2006
A questionnaire survey on the management of Graves' orbitopathy in Europe, P Perros, L Baldeschi, et al.
Journal of Endocrinological Investigation|February 9, 2017
Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?L Bartalena, G Veronesi, G E Krassas, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 5, 2026
Measurement properties of the USER-Participation Restriction subscale and PROMIS<sup>®</sup> Ability to Participate in Social roles and Activities in in- and outpatient rehabilitation populationsB M P Mourits, E W M Scholten, J A de Graaf, et al.
European Journal of Endocrinology|August 18, 2006
Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers, W M Wiersinga, P Perros, et al.
The British Journal of Ophthalmology|November 26, 2008
Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures, M P Mourits, H Bijl, et al.
Pageof 7